查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2095020

家庭輸液服務市場：全球市場預測（2026-2032 年）

Home Infusion Services Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，家庭輸液服務市場將成長至 524.9 億美元，複合年成長率為 10.35%。

主要市場統計數據
基準年（2025 年） 263.2億美元
預計年份（2026年） 285.6億美元
預測年份（2032年） 524.9億美元
複合年成長率（） 10.35%

家庭輸液服務：執行摘要

隨著醫院、保險公司、醫療保健專業人員和患者越來越重視在院外環境中提供安全、臨床管理的醫療服務，居家輸液服務正成為現代醫療保健服務的重要組成部分。這種服務模式支持在家庭環境中透過靜脈、皮下、硬膜外或其他輸液途徑給藥和輸液，包括抗感染疾病治療、腸外營養、免疫球蛋白療法、化療支持、疼痛管理、補液和特殊生物製藥。其臨床意義體現在醫院容量日益緊張、慢性病患病率不斷上升、人口老化以及對以患者為中心的醫療服務需求不斷成長等因素。這種轉變也符合以價值為基礎的醫療的目標，即減少不必要的住院治療、確保醫療服務的連續性，並提高需要反覆或長期治療的患者的便利性。有效的家庭輸液項目依賴合格護理師的支持、無菌配藥、藥房監管、設備可靠性、護理協調、病患教育以及對感染控制標準的遵守。隨著監管機構和認證框架對藥品安全、文件記錄和結果監測的要求不斷提高，該領域正從以便利性為中心的服務發展成為專科藥房、急性後期護理和慢性病管理的重要延伸。

家庭輸液治療領域的一次根本性改變。

受「家庭醫院」模式、專科藥物創新、數位化護理協調以及保險公司對成本效益高的護理場所的關注等因素推動，家庭輸液服務格局正在發生根本性變革。生物製藥和複雜注射療法的廣泛應用，增加了對可在急性護理機構之外安全進行的臨床管理輸液途徑的需求。同時，醫療系統正在利用家庭療法來解決延遲出院、降低再入院風險並提高重症患者的床位可用性。攜帶式輸液幫浦、彈性體裝置、遠端監測工具、電子病歷和低溫運輸物流的進步，提高了家庭給藥在日益複雜的治療中的可行性。熟練的輸液護理師和藥局人員短缺仍然是一項嚴峻挑戰，這進一步凸顯了標準化流程、臨床醫生培訓和集中式護理協調的重要性。有關無菌配製、藥物核查、感染預防和不利事件報告的監管也在改變工作方式。因此，醫療保健環境正在形成，能夠展現高臨床品質、快速患者入院、與保險公司協調以及可靠的供應鏈運營的醫療保健提供者，在支持永續的家庭輸液護理方面，將處於更有利的地位。

人工智慧對家庭輸液服務的累積影響

人工智慧 (AI) 正透過改善護理協調、營運效率、安全監測和病患參與度，開始影響居家輸液服務。 AI 驅動的排班系統能夠根據治療的複雜程度、地點和患者病情嚴重程度來分配護理資源，這在許多地區居家醫療和輸液護理資源仍然緊張的情況下變得日益重要。預測分析有助於風險分層，識別併發症、漏服藥物、血管通路問題、用藥依從性差或再次入院的高風險患者，從而使護理團隊能夠優先採取乾預措施。 AI 驅動的庫存規劃可以透過預測靜脈輸液用品、輸液幫浦、無菌產品和低溫運輸配送的需求來減少藥物延誤。在臨床工作流程中，利用自然語言處理可以從轉診信、出院小結和預核准記錄中提取相關信息，從而減輕行政負擔並加快治療啟動。然而，AI 的累積效應取決於資料品質、互通性、管治、網路安全和人工監督。對於家庭輸液治療服務提供者而言，負責任地實施人工智慧需要透明的演算法、臨床醫生的檢驗、隱私保護以及遵守醫療保健法規。人工智慧並非旨在取代臨床判斷，而是為了增強整個分散式居家照護網路的決策支援、應對力和一致性。

家庭輸液服務的區域分析

在亞太地區，隨著人口老化、糖尿病、癌症、自體免疫疾病以及康復後護理需求的成長，都市區和都市區醫療保健系統對家庭輸液服務的需求日益增加。擁有先進醫院基礎設施、專業藥房能力和先進數位醫療技術的國家，在推廣複雜的家庭輸液治療方面具有得天獨厚的優勢；而在新興市場，可及性、可負擔性、臨床醫生配備以及患者安全標準至關重要。北美仍然是家庭輸液服務最成熟的地區之一，這得益於其完善的專業藥房網路、保險公司報銷機制、出院支持項目以及積極推行居家慢性病管理。在拉丁美洲，需求成長與私人醫療保健、都市區專科醫療中心的擴張以及人們日益認知到家庭護理是緩解醫院堵塞的有效途徑密切相關，但報銷機制不均衡、護士配備不足以及後勤基礎設施落後等問題正在影響家庭輸液服務的普及。歐洲的特點是全民健保或公共醫療體系、嚴格的藥品安全法規以及對社區護理日益重視，因此，西歐地區家庭輸液已更廣泛地融入到急性後期護理和專科治療路徑中。在中東，家庭輸液的推廣得益於醫療現代化、私立醫院網路以及旨在改善醫療服務可及性並減輕住院患者負擔的政府舉措，尤其是在高所得的海灣地區。非洲的情況則更為複雜，家庭輸液的應用主要集中在具備低溫運輸物流、訓練有素的護理人員、輸液設備和藥房支援的私立和都市區醫療機構。家庭輸液的進一步推廣取決於基礎設施、監管能力、經濟實力和人力資源發展。

按主要集團分類的分析：東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協市場，隨著醫療保健系統的發展以適應都市區成長、醫療旅遊、慢性病盛行率上升以及私人醫療服務提供者網路的擴張，居家輸液服務的重要性日益凸顯。然而，居家輸液服務的可近性差異顯著，主要取決於保險報銷系統的成熟度、數位化醫療實施的準備程度以及居家醫療相關法規。在海灣合作理事會（GCC）國家，居家輸液的發展得益於醫療保健轉型計劃、對數位化醫療的大量投資以及對高品質居家照護服務的需求，同時這些國家擁有相對完善的醫院基礎設施，並且越來越重視減少不必要的住院治療。歐盟透過藥品安全標準、資料保護法規、跨境監管協調以及強調「居家養老」和社區護理的政策，為居家輸液提供了系統性的環境。然而，各國報銷體系和臨床實務的差異仍影響著服務的可近性。金磚國家由於其大規模的患者群體和日益加重的慢性病負擔，以及醫療保健可近性、國內製藥能力、專業醫療基礎設施和居家照護護理法規等方面的差異，呈現出多樣化的發展機會。七國集團（G7）國家通常已為先進的居家輸液模式做好充分準備，這得益於它們能夠獲得成熟的專科藥物、具備數位化醫療能力、擁有完善的法律規範、擁有認證的診療路徑，以及支付方對價值醫療的重視。北約成員國雖然並非醫療衛生集團，但也擁有許多先進的醫療衛生系統，而韌性計劃、安全的醫療衛生供應鏈和數位化基礎設施對於居家居家醫療服務的連續性至關重要。

針對各國家庭輸液服務進行分析。

美國擁有高度發展的家庭輸液服務體系，該體係由與專業藥房、居家醫療提供者、保險公司簽訂的合約、醫生轉診以及在家中開展的感染疾病物、免疫球蛋白、腸外營養和生物製藥等療法提供支持。在加拿大，公共醫療保健優先事項、省級護理模式以及減輕急診護理負擔的努力為家庭輸液的實施提供了支持，但地域分散和省級報銷差異影響了服務的提供。在墨西哥和巴西，受私人醫療保健、都市區專科護理和慢性病管理發展推動，家庭輸液的需求正在成長，但服務獲取方面的差異、複雜的報銷系統和物流限制仍然是重要的障礙。在英國，社區護理、出院最佳化和國家醫療服務體系（NHS）容量管理受到重視，家庭輸液在某些能夠確保臨床管治和護理支持的療法中發揮著至關重要的作用。德國、法國、義大利和西班牙受益於健全的醫療保健體系、老齡化人口以及專科藥物的使用，其應用受到國家醫保報銷規則、藥房法規、藥品安全要求和家庭護理體系的影響。俄羅斯的家庭輸液環境受到區域醫療保健差異、以醫院為中心的傳統醫療模式以及幅員遼闊的國土所帶來的後勤挑戰的影響。在中國，隨著慢性病負擔加重和醫院面臨需求壓力，人們對居家醫療的興趣日益濃厚，但家庭輸液的更廣泛應用需要明確的法規、訓練有素的人員、完善的醫保報銷體係以及病人安全框架。印度擁有龐大的慢性疾病患者群體、不斷成長的私人醫院數量以及不斷擴大的居家醫療服務，因此具有巨大的潛力，但成本效益、標準化和熟練護理人員的供應仍然是主要障礙。在日本，老齡化社會、高標準的醫療水平以及對居家照護政策的重視，支持有選擇地使用家庭輸液，尤其是在優先考慮老年患者持續護理的情況下。在澳大利亞，先進的醫療基礎設施與地理環境的挑戰並存，如果護理和低溫運輸物流到位，居家輸液療法可以有效減少住院次數。在韓國，數位醫療的發展、醫院的優質水平以及對慢性病管理的需求創造了有利的環境，但報銷制度和醫療服務提供者之間的合作正在影響著這項業務的擴張。

為家庭輸液行業領導者提供的實用建議

隨著居家輸液服務在醫療保健服務中日益重要，產業領導者必須優先考慮臨床品質、病人安全和營運韌性。醫療機構需要加強標準化的病患接收、藥物調整、血管通路評估、不利事件升級和感染預防流程，以確保治療效果的一致性。投資於技能嫻熟的輸液護理師、藥劑師主導的治療管理以及持續的專業發展培訓至關重要，尤其對於高風險治療和免疫力缺乏患者。各機構應透過減少預核准延遲、提高文件準確性以及與處方醫生和醫院出院團隊建立清晰的溝通管道，來改善保險公司和轉診流程。應積極部署能夠顯著改善排班、遠端監測、病患教育、庫存可見性和用藥依從性追蹤的數位化工具。供應鏈韌性必須包括低溫運輸檢驗、備用輸液幫浦的可用性、無菌配製品質保證、網路安全措施以及應對藥品短缺的緊急時應對計畫。此外，領導者應建構以病人為中心的醫療服務模式，包括多語言教育、看護者培訓、全天候臨床支援以及清晰的緊急情況應對指南。與醫院、專科診所、社區藥局和居家醫療網路建立策略夥伴關係，可以提高醫療服務的連續性，擴大服務覆蓋範圍，同時確保臨床課責到位。

用於分析家庭輸液服務的分析方法

本報告採用系統性的二手研究途徑，重點關注檢驗的醫療、監管、臨床和行業資訊來源。分析方法包括衛生部門、認證機構和報銷機構發布的公共指南；居家醫院政策文件；同行評審的臨床文獻；人口統計資料庫；慢性病負擔報告；以及與急性後期護理和專科藥房護理相關的證據分析。報告對多個資訊來源類別的資訊進行交叉比對，以評估服務採納因素、監管考慮、區域差異、治療趨勢、技術採納和營運挑戰。報告特別關注已驗證的因素，例如人口老化、慢性病盛行率、醫院容量限制、居家醫療專業人員短缺、藥品安全要求、低溫運輸管理、無菌配製標準以及數位醫療的採納。本分析避免了不合理的假設，並且不包含市場規模/估算、佔有率估算和預測。報告以定性方式呈現各國和各地區的觀察結果，以反映檢驗的醫療保健系統的特徵、政策方向、基礎設施發展以及採納障礙。本研究方法強調資料完整性、情境解釋以及與家庭輸液服務策略決策的相關性。

結論：家庭輸液服務的未來

居家輸液服務正從小眾的急性後期照護選擇，轉變為在患者家中提供複雜治療的重要策略模式。慢性病的增加、人口老化、特殊藥物的使用、醫院容量的限制以及對更便捷照護的需求，都推動了這一領域的發展。儘管不同地區的部署情況會因報銷制度、人員配備水平、藥房基礎設施、法規和數位醫療成熟度而有所不同，但發展方向是明確的：安全、協調且技術驅動的輸液護理正變得日益成為全球醫療保健系統不可或缺的一部分。人工智慧和數位平台，如果在嚴格的臨床監督下負責任地實施，將進一步提升排班、風險識別、供應鏈管理和病患參與度。擁有嚴格安全標準、技術精湛的護理團隊、與保險公司建立合作關係、可靠的物流以及以患者為中心的支持的行業領導者，將最有能力推動居家輸液服務的發展。長遠來看，機會不僅在於將治療轉移到醫院之外，更在於建構能夠改善需要輸液治療的患者的就醫便利性、治療連續性和治療品質的綜合護理模式。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入（GTM）策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析（ROI）和成本效益分析（CBA）

第6章：人工智慧（AI）的累積影響（2026 年）

第7章：家庭輸液服務市場：依服務類型分類

  • 藥局服務
  • 護理服務
  • 病患監測

第8章：家庭輸液服務市場：依交付方式分類

  • 靜脈
  • 皮下

第9章：家庭輸液服務市場：依給藥途徑分類

  • 中央靜脈
  • 周邊血管

第10章：家庭輸液服務市場：依治療類型分類

  • 抗生素輸注
    • Aminoglycosides抗生素
    • BETA-內醯胺類抗生素
    • Fluoroquinolones抗生素
  • 腫瘤學
    • 靜脈注射抗癌藥物
    • 皮下注射抗癌藥物
  • 疼痛管理
  • 腸外營養

第11章：家庭輸液服務市場：依最終用戶分類

  • 診所
  • 居家治療
  • 醫院

第12章：家庭輸液服務市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：家庭輸液服務市場：依群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：家庭輸液服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市佔率分析（2025 年）
  • FPNV定位矩陣（2025）
  • 市場集中度分析（2025 年）
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析（2025 年）
  • 產品系列分析（2025 年）
  • 基準分析（2025 年）

第16章：公司簡介

  • Accredo Health Group, Inc.
  • Amedisys, Inc. by UnitedHealth Group
  • Amerita, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Caesarea Medical Electronics Ltd.
  • CareCentrix, Inc.
  • CVS Health Corporation
  • Fresenius Kabi AG
  • HCA Healthcare, Inc.
  • ICU Medical, Inc.
  • InfuSystem Holdings, Inc.
  • JMS Co., Ltd.
  • Lincare Holdings Inc.
  • Medtronic PLC
  • Moog Inc.
  • Nipro Corporation
  • Option Care Health, Inc.
  • Orsini
  • Paragon Healthcare, Inc. by Elevance Health
  • PharMerica Corporation
  • PromptCare Companies, Inc.
  • Terumo Corporation
Product Code: MRR-3A2E844FEC05

The Home Infusion Services Market is projected to grow by USD 52.49 billion at a CAGR of 10.35% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 26.32 billion
Estimated Year [2026] USD 28.56 billion
Forecast Year [2032] USD 52.49 billion
CAGR (%) 10.35%

Home Infusion Services Executive Summary

Home infusion services are becoming a critical component of modern healthcare delivery as hospitals, payers, clinicians, and patients increasingly prioritize safe, clinically supervised treatment outside institutional settings. The service model supports the administration of medications and fluids through intravenous, subcutaneous, epidural, or other infusion routes in the home, including anti-infective therapy, parenteral nutrition, immunoglobulin therapy, chemotherapy support, pain management, hydration, and specialty biologics. Clinical relevance is supported by documented pressure on hospital capacity, higher prevalence of chronic diseases, aging populations, and stronger demand for patient-centered care. The shift also aligns with value-based healthcare objectives by reducing avoidable inpatient utilization, supporting continuity of care, and improving convenience for individuals who require recurring or long-duration therapy. Effective home infusion programs depend on licensed nursing support, sterile compounding, pharmacy oversight, device reliability, care coordination, patient training, and adherence to infection prevention standards. As regulatory bodies and accreditation frameworks strengthen expectations for medication safety, documentation, and outcomes monitoring, the sector is evolving from a convenience-driven service into an essential extension of specialty pharmacy, post-acute care, and chronic disease management.

Transformative Shifts in the Home Infusion Landscape

The home infusion services landscape is undergoing transformative shifts driven by hospital-at-home models, specialty drug innovation, digital care coordination, and payer focus on cost-effective sites of care. The expansion of biologics and complex injectable therapies is increasing demand for clinically managed infusion pathways that can be delivered safely outside acute care settings. At the same time, health systems are using home-based therapy to address discharge delays, reduce readmission risk, and improve bed availability for higher-acuity patients. Advances in ambulatory infusion pumps, elastomeric devices, remote monitoring tools, electronic medication administration records, and cold-chain logistics are improving the feasibility of home administration for increasingly complex therapies. Workforce constraints remain a defining challenge, particularly in skilled infusion nursing and pharmacy operations, prompting greater emphasis on standardized protocols, clinician training, and centralized care coordination. Regulatory scrutiny around sterile compounding, medication reconciliation, infection prevention, and adverse event reporting is also reshaping operational practices. The result is a healthcare environment where providers that demonstrate clinical quality, rapid patient onboarding, payer navigation, and reliable supply chain execution are better positioned to support sustainable home-based infusion care.

Cumulative Impact of Artificial Intelligence on Home Infusion Services

Artificial intelligence is beginning to influence home infusion services by improving care coordination, operational efficiency, safety surveillance, and patient engagement. AI-enabled scheduling can help match nursing resources with therapy complexity, geography, and patient acuity, which is increasingly important as home health and infusion nursing capacity remains constrained in many regions. Predictive analytics can support risk stratification by identifying patients more likely to experience complications, missed doses, vascular access issues, medication adherence gaps, or hospital readmission, allowing care teams to prioritize interventions. AI-assisted inventory planning may reduce medication delays by anticipating demand for infusion supplies, pumps, sterile products, and cold-chain deliveries. In clinical workflows, natural language processing can help extract relevant information from referral documents, discharge summaries, and prior authorization records, reducing administrative burden and accelerating therapy initiation. However, the cumulative impact of AI depends on data quality, interoperability, governance, cybersecurity, and human oversight. For home infusion providers, responsible adoption requires transparent algorithms, clinician validation, privacy safeguards, and compliance with healthcare regulations. AI is not replacing clinical judgment; it is strengthening decision support, responsiveness, and consistency across distributed home-based care networks.

Key Regional Insights for Home Infusion Services

Asia-Pacific is experiencing rising demand for home infusion services as aging populations, diabetes, cancer, autoimmune disorders, and post-acute care needs increase across urban and semi-urban healthcare systems. Countries with advanced hospital infrastructure, specialty pharmacy capabilities, and digital health adoption are better positioned to scale complex infusion therapy at home, while emerging markets are prioritizing access, affordability, clinician availability, and patient safety standards. North America remains one of the most mature regions for home infusion services due to established specialty pharmacy networks, payer reimbursement pathways, hospital discharge programs, and strong adoption of home-based chronic disease management. In Latin America, demand is linked to private healthcare expansion, urban specialty care centers, and increasing recognition of home-based treatment as a way to reduce hospital congestion, though uneven reimbursement, nurse availability, and logistics infrastructure influence adoption. Europe is shaped by universal or publicly funded healthcare systems, strong medication safety regulation, and increasing emphasis on community-based care, with Western Europe generally showing broader integration of home infusion into post-acute and specialty therapy pathways. The Middle East is advancing home infusion through healthcare modernization, private hospital networks, and government initiatives aimed at improving access and reducing inpatient burden, particularly in high-income Gulf markets. Africa presents a more uneven landscape, with home infusion adoption concentrated in private and urban healthcare settings where cold-chain logistics, trained nurses, infusion devices, and pharmacy support are available; broader expansion depends on infrastructure, regulatory capacity, affordability, and workforce development.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are increasingly relevant for home infusion services as healthcare systems respond to urban population growth, medical tourism, chronic disease prevalence, and expanding private provider networks, though adoption differs significantly by reimbursement maturity, digital health readiness, and home healthcare regulation. GCC countries are advancing home-based infusion through healthcare transformation programs, high investment in digital health, and demand for premium home care services, supported by comparatively strong hospital infrastructure and a growing focus on reducing avoidable inpatient stays. The European Union provides a structured environment for home infusion through medicine safety standards, data protection rules, cross-border regulatory alignment, and policy emphasis on aging-in-place and community care; however, country-level reimbursement and clinical practice differences continue to shape service availability. BRICS countries represent diverse opportunities, combining large patient populations and rising chronic disease burdens with varying levels of healthcare access, domestic pharmaceutical capacity, specialty care infrastructure, and home care regulation. G7 economies generally show stronger readiness for advanced home infusion models due to established specialty drug access, digital health capabilities, regulatory oversight, accredited care pathways, and payer emphasis on value-based care. NATO member countries, while not a healthcare bloc, include many advanced health systems where resilience planning, secure medical supply chains, and digital infrastructure are increasingly relevant to home-based medical services, particularly for continuity of care during public health disruptions, emergency preparedness needs, or hospital capacity constraints.

Key Country Insights for Home Infusion Services

The United States has a highly developed home infusion services ecosystem supported by specialty pharmacies, home health providers, payer contracting, physician referrals, and established use of therapies such as anti-infectives, immunoglobulins, parenteral nutrition, and biologics in home settings. Canada's adoption is supported by publicly funded healthcare priorities, provincial care models, and efforts to reduce acute-care pressure, though geographic dispersion and provincial reimbursement variation affect service delivery. Mexico and Brazil are seeing demand supported by private healthcare growth, urban specialty medicine, and chronic disease management, while access disparities, reimbursement complexity, and logistics constraints remain important barriers. The United Kingdom emphasizes community-based care, discharge optimization, and National Health Service capacity management, making home infusion relevant for selected therapies where clinical governance and nursing support are available. Germany, France, Italy, and Spain benefit from strong healthcare systems, aging populations, and specialty drug use, with adoption influenced by national reimbursement rules, pharmacy regulation, medication safety requirements, and home nursing capacity. Russia's home infusion environment is shaped by regional healthcare variation, hospital-centered care traditions, and logistics challenges across large territories. China is expanding interest in home healthcare as chronic disease burden rises and hospitals face demand pressure, but broader home infusion adoption depends on regulatory clarity, trained workforce availability, reimbursement development, and patient safety frameworks. India has strong potential due to large chronic disease populations, growing private hospitals, and expanding home healthcare services, while affordability, standardization, and skilled nursing supply remain key barriers. Japan's aging society, high healthcare standards, and home care policy focus support selected home infusion use, especially where continuity of care for older patients is prioritized. Australia combines advanced healthcare infrastructure with geographic challenges, making home infusion valuable for reducing hospital visits when nursing coverage and cold-chain logistics can be assured. South Korea's digital health readiness, hospital quality, and chronic disease management needs create a favorable environment, though reimbursement and provider integration influence scalability.

Actionable Recommendations for Home Infusion Industry Leaders

Industry leaders should prioritize clinical quality, patient safety, and operational resilience as home infusion services become more central to healthcare delivery. Providers should strengthen standardized intake, medication reconciliation, vascular access assessment, adverse event escalation, and infection prevention protocols to support consistent outcomes. Investment in skilled infusion nurses, pharmacist-led therapy management, and ongoing competency training is essential, particularly for high-risk therapies and immunocompromised patients. Organizations should improve payer and referral workflows by reducing prior authorization delays, enhancing documentation accuracy, and creating clear communication channels with prescribers and hospital discharge teams. Digital tools should be adopted where they measurably improve scheduling, remote monitoring, patient education, inventory visibility, and adherence tracking. Supply chain resilience must include cold-chain validation, backup pump availability, sterile compounding quality assurance, cybersecurity controls, and contingency planning for drug shortages. Leaders should also develop patient-centric service models that include multilingual education, caregiver training, 24/7 clinical support, and clear instructions for emergency scenarios. Strategic partnerships with hospitals, specialty clinics, community pharmacies, and home health networks can improve continuity of care and expand access while maintaining clinical accountability.

Research Methodology for Home Infusion Services Analysis

This executive summary is developed using a structured secondary research approach focused on verified healthcare, regulatory, clinical, and industry sources. The methodology includes analysis of publicly available guidance from health authorities, accreditation bodies, reimbursement agencies, hospital-at-home policy references, peer-reviewed clinical literature, demographic databases, chronic disease burden reports, and evidence related to post-acute and specialty pharmacy care. Insights are triangulated across multiple source categories to evaluate service adoption drivers, regulatory considerations, regional differences, therapy trends, technology enablement, and operational challenges. Particular attention is given to documented factors such as aging populations, chronic disease prevalence, hospital capacity pressure, home healthcare workforce constraints, medication safety requirements, cold-chain management, sterile compounding standards, and digital health implementation. The analysis avoids unsupported assumptions and excludes market sizing, share estimation, and forecasting. Country and regional observations are presented qualitatively to reflect verified healthcare system characteristics, policy direction, infrastructure readiness, and adoption barriers. The research approach emphasizes data integrity, contextual interpretation, and relevance for strategic decision-making in home infusion services.

Conclusion: The Future of Home Infusion Services

Home infusion services are moving from a niche post-acute option to a strategically important model for delivering complex therapies in patient homes. The sector is being shaped by chronic disease growth, aging demographics, specialty medication use, hospital capacity constraints, and demand for more convenient care. Regional adoption varies based on reimbursement, workforce readiness, pharmacy infrastructure, regulation, and digital health maturity, but the direction of travel is clear: safe, coordinated, and technology-enabled infusion care is becoming more integral to healthcare systems worldwide. Artificial intelligence and digital platforms will further enhance scheduling, risk identification, supply chain management, and patient engagement when implemented responsibly with strong clinical oversight. Industry leaders that combine rigorous safety standards, skilled care teams, payer alignment, reliable logistics, and patient-centered support will be best positioned to advance home infusion services. The long-term opportunity lies not merely in shifting therapy out of hospitals, but in building integrated care models that improve access, continuity, and quality for patients requiring infusion-based treatment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Home Infusion Services Market, by Service Type

  • 7.1. Introduction
  • 7.2. Compounding Services
  • 7.3. Nursing Services
  • 7.4. Patient Monitoring

8. Home Infusion Services Market, by Delivery Mode

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Subcutaneous

9. Home Infusion Services Market, by Route Of Administration

  • 9.1. Introduction
  • 9.2. Central
  • 9.3. Peripheral

10. Home Infusion Services Market, by Therapy Type

  • 10.1. Introduction
  • 10.2. Antibiotic Infusion
    • 10.2.1. Aminoglycosides
    • 10.2.2. Beta Lactams
    • 10.2.3. Fluoroquinolones
  • 10.3. Oncology
    • 10.3.1. Intravenous Oncology Agents
    • 10.3.2. Subcutaneous Oncology Agents
  • 10.4. Pain Management
  • 10.5. Parenteral Nutrition

11. Home Infusion Services Market, by End User

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Healthcare Agencies
  • 11.4. Hospitals

12. Home Infusion Services Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Home Infusion Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Home Infusion Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Accredo Health Group, Inc.
  • 16.2. Amedisys, Inc. by UnitedHealth Group
  • 16.3. Amerita, Inc.
  • 16.4. B. Braun Melsungen AG
  • 16.5. Baxter International Inc.
  • 16.6. Becton, Dickinson and Company
  • 16.7. Caesarea Medical Electronics Ltd.
  • 16.8. CareCentrix, Inc.
  • 16.9. CVS Health Corporation
  • 16.10. Fresenius Kabi AG
  • 16.11. HCA Healthcare, Inc.
  • 16.12. ICU Medical, Inc.
  • 16.13. InfuSystem Holdings, Inc.
  • 16.14. JMS Co., Ltd.
  • 16.15. Lincare Holdings Inc.
  • 16.16. Medtronic PLC
  • 16.17. Moog Inc.
  • 16.18. Nipro Corporation
  • 16.19. Option Care Health, Inc.
  • 16.20. Orsini
  • 16.21. Paragon Healthcare, Inc. by Elevance Health
  • 16.22. PharMerica Corporation
  • 16.23. PromptCare Companies, Inc.
  • 16.24. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME INFUSION SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL HOME INFUSION SERVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL HOME INFUSION SERVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL HOME INFUSION SERVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL HOME INFUSION SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COMPOUNDING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COMPOUNDING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COMPOUNDING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NURSING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NURSING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NURSING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANTIBIOTIC INFUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AMINOGLYCOSIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BETA LACTAMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BETA LACTAMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BETA LACTAMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS ONCOLOGY AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS ONCOLOGY AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS ONCOLOGY AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SUBCUTANEOUS ONCOLOGY AGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SUBCUTANEOUS ONCOLOGY AGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SUBCUTANEOUS ONCOLOGY AGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PARENTERAL NUTRITION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HOME HEALTHCARE AGENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL HOME HEALTHCARE AGENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL HOME HEALTHCARE AGENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. GCC HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GCC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. GCC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 127. GCC HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 129. GCC HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. GCC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. G7 HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. G7 HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. G7 HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 150. G7 HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 151. G7 HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. G7 HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 153. G7 HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. G7 HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NATO HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. NATO HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NATO HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 159. NATO HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. CANADA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. CANADA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. CANADA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 175. CANADA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 176. CANADA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. CANADA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 178. CANADA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. CANADA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. MEXICO HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 183. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 184. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 186. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. MEXICO HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. BRAZIL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 191. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 192. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 194. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. BRAZIL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED KINGDOM HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. GERMANY HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 207. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 208. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 210. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 211. GERMANY HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. FRANCE HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 215. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 216. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 218. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. FRANCE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. RUSSIA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 223. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 224. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 226. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. RUSSIA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. ITALY HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. ITALY HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ITALY HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 231. ITALY HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 232. ITALY HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ITALY HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 234. ITALY HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. ITALY HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. SPAIN HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 239. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 240. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 242. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. SPAIN HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 247. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 248. CHINA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 250. CHINA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. INDIA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. INDIA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. INDIA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 255. INDIA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 256. INDIA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. INDIA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 258. INDIA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 259. INDIA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. JAPAN HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 261. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 262. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 263. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 264. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 266. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. JAPAN HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 271. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 272. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 274. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 275. AUSTRALIA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 279. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 280. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2032 (USD MILLION)
  • TABLE 282. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. SOUTH KOREA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • TABLE 285. GLOBAL HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025